Chester County News and Community Website
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) has announced promising new data from its IM-PROVE I Phase 2a clinical trial, suggesting significant advancements in treatment for chronic hepatitis B …
Arbutus Biopharma’s Clinical Trial Shows Promise for Hepatitis B Treatment Read More WARMINSTER, PA and OXFORD, United Kingdom — Arbutus Biopharma Corporation and Barinthus Biotherapeutics recently unveiled encouraging preliminary results from their Phase 2a IM-PROVE II clinical trial at the American Association …
Promising New Data from Hepatitis B Trial by Arbutus and Barinthus Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has greenlit the marketing of a ground-breaking Hepatitis C virus (HCV) test, developed by Cepheid, marking a significant step in …
FDA Approves Revolutionary Hepatitis C Test: A Game Changer in Disease Diagnosis and Management Read More